We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Sandbox Reserved 1070
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
{{Sandbox_Reserved_Butler_CH462_Sp2015_#}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | {{Sandbox_Reserved_Butler_CH462_Sp2015_#}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | ||
==MgtC: A Virulence Factor From ''Mycobacterium tuberculosis''== | ==MgtC: A Virulence Factor From ''Mycobacterium tuberculosis''== | ||
| - | <StructureSection load='2lqj' size='340' side='right' caption='C-terminal Domain of Mg2+ transport P-type ATPase C (PDB: [http://www.rcsb.org/pdb/explore.do?structureId=2lqj 2LQJ]' scene=' | + | <StructureSection load='2lqj' size='340' side='right' caption='C-terminal Domain of Mg2+ transport P-type ATPase C (PDB: [http://www.rcsb.org/pdb/explore.do?structureId=2lqj 2LQJ])' scene=''> |
==Introduction== | ==Introduction== | ||
Tuberculosis, caused by Mycobacterium tuberculosis, is a respiratory infection still prevalent throughout the world. During the last decade, the emergence of multi-drug resistant strains of M. tuberculosis has given rise to the need for the development of new antibiotics in order to combat the infection. In order to develop an efficacious antibiotic, the drug must be able to target a unique aspect of the bacteria, such as a protein, that is critical for its full virulence and survival. MgtC, an integral protein embedded in the extracellular membrane of M. tuberculosis, has recently been hypothesized as a novel drug target to resolve tuberculosis infections. The targeting of MgtC was a result of observing that upon deletion of the protein from M. tuberculosis, the bacteria are no longer able to survive due to inhibition of intramacrophage growth. | Tuberculosis, caused by Mycobacterium tuberculosis, is a respiratory infection still prevalent throughout the world. During the last decade, the emergence of multi-drug resistant strains of M. tuberculosis has given rise to the need for the development of new antibiotics in order to combat the infection. In order to develop an efficacious antibiotic, the drug must be able to target a unique aspect of the bacteria, such as a protein, that is critical for its full virulence and survival. MgtC, an integral protein embedded in the extracellular membrane of M. tuberculosis, has recently been hypothesized as a novel drug target to resolve tuberculosis infections. The targeting of MgtC was a result of observing that upon deletion of the protein from M. tuberculosis, the bacteria are no longer able to survive due to inhibition of intramacrophage growth. | ||
Revision as of 16:46, 7 April 2015
| This Sandbox is Reserved from 02/09/2015, through 05/31/2016 for use in the course "CH462: Biochemistry 2" taught by Geoffrey C. Hoops at the Butler University. This reservation includes Sandbox Reserved 1051 through Sandbox Reserved 1080. |
To get started:
More help: Help:Editing |
MgtC: A Virulence Factor From Mycobacterium tuberculosis
| |||||||||||
